916483-56-2Relevant articles and documents
QUINAZOLINE DERIVATIVES
-
Page/Page column 12, (2010/07/08)
The invention provided a compound of formula (I) for use in the treatment of disease, in particular proliferative diseases such as cancer and for use in the preparation of medicaments for use in the treatment of proliferative diseases; the invention also
Synthesis and mesomorphic properties of two series of laterally fluorinated symmetric ester liquid crystals
Wei, Qiang,Yuan, Xiaotao,Zhang, Lipei,Wang, Liping,Yang, Huai,Wang, Yangbin
experimental part, p. 52 - 60 (2010/03/25)
Two series of symmetric ester liquid crystals (nAFBHQ and nADFBHQ) with lateral fluorine atoms have been synthesized. Their chemical structures were measured by FTIR, 1H NMR, and elemental analysis (EA). Their mesomorphic properties were investigated by d
Novel synthesis of differentially substituted 5,7-dialkoxyquinazolin-4-ones
Foote, Kevin M.,Hatter, Glenn
, p. 2575 - 2583 (2008/12/22)
The preparation of 7-ethoxy-5-fluoroquinazolin-4-one, starting from 3,5-difluorophenol, is described. Further reaction with alkoxide then gives differentially substituted 5,7-dialkoxyquinazolin-4-ones. Copyright Taylor & Francis Group, LLC.
QUINAZOLINES AND THEIR USE AS AURORA KINASE INHIBITORS
-
, (2010/11/25)
The invention provided a compound of formula (I) for use in the treatment of disease, in particular proliferative diseases such as cancer and for use in the preparation of medicaments for use in the treatment of proliferative diseases; the invention also